• LAST PRICE
    0.3724
  • TODAY'S CHANGE (%)
    Trending Down-0.0054 (-1.4293%)
  • Bid / Lots
    0.3527/ 4
  • Ask / Lots
    0.3800/ 95
  • Open / Previous Close
    0.3800 / 0.3778
  • Day Range
    Low 0.3515
    High 0.3800
  • 52 Week Range
    Low 0.3100
    High 2.0799
  • Volume
    63,663
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 0.3778
TimeVolumeAWH
09:32 ET8950.38
09:33 ET3500.371
09:46 ET5300.3799
09:50 ET12800.370001
09:57 ET8880.370101
11:05 ET5000.3701
11:09 ET5000.3702
11:18 ET53000.3701
11:20 ET4670.371501
11:25 ET4950.37
11:32 ET1650.37
11:41 ET5000.3728
11:43 ET5000.371399
11:59 ET2000.37
12:12 ET106770.3714
12:28 ET1610.37
12:37 ET139540.362
01:02 ET5000.363
01:29 ET1440.3573
02:09 ET3000.35847
02:18 ET1320.357
02:39 ET1500.357799
02:59 ET2780.3515
03:06 ET3000.3515
03:12 ET2000.3515
03:14 ET7500.3516
03:15 ET4780.3515
03:19 ET4000.3515
03:24 ET5590.3515
03:26 ET2210.3528
03:32 ET13000.3534
03:53 ET2050.3724
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAWH
Aspira Women's Health Inc
46.3M
-1.4x
---
United StatesSLS
Sellas Life Sciences Group Inc
55.0M
-1.2x
---
United StatesAVTX
Avalo Therapeutics Inc
53.7M
-1.1x
---
United StatesUBX
UNITY Biotechnology Inc
39.6M
-0.1x
---
United StatesALGS
Aligos Therapeutics Inc
41.1M
-0.4x
---
United StatesONCT
Oncternal Therapeutics Inc
52.7M
-1.2x
---
As of 2022-12-03

Company Information

Aspira Women’s Health Inc. is engaged in discovering, developing and utilization of testing options and bio-analytical solutions. Its products include OVA1 and Overa, OVA1plus, Aspira GenetiX and Aspira Synergy. OVA1 is a blood test that is intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass for which surgery is planned when the physician’s independent clinical, and Overa is intended to maintain OVA1’s high sensitivity. OVA1plus is a reflex test performed for those OVA1 test results that are in the intermediate risk range. Aspira GenetiX is a genetic test for gynecologic cancer risk, with a focus on female reproductive cancers, including breast, ovarian, endometrial, uterine and cervical cancers. Aspira Synergy is an en-suite, cloud-based technology transfer solution that provides an end-to-end solution from specimen collection to a customized white-label report for clinical laboratories to internalize testing of its products.

Contact Information

Headquarters
Suite 100 12117 Bee Caves Road Building ThreeAUSTIN, TX, United States 78738
Phone
512-519-0400
Fax
512-439-6980

Executives

Executive Chairman of the Board
Valerie Palmieri
President, Chief Executive Officer, Director
Nicole Sandford
Chief Financial Officer
Robert Beechey
Interim Chief Financial Officer
Marlene Mclennan
Chief Operating and Scientific Officer
Ryan Phan

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$46.3M
Revenue (TTM)
$7.9M
Shares Outstanding
124.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.72
EPS
$-0.27
Book Value
$0.27
P/E Ratio
-1.4x
Price/Sales (TTM)
5.9
Price/Cash Flow (TTM)
---
Operating Margin
-458.13%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.